-- Viridian Therapeutics (VRDN) has an average rating of Buy and mean price target of $33.75, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $18.75, Change: $+4.69, Percent Change: +33.36%